Molly highlights HIL Applied Medical's groundbreaking laser-based radiotherapy for cancer patients, showcasing the potential for growth in the $20 billion proton therapy market. Accredited investors can explore these cutting-edge opportunities by joining rCrowd for free at rcrowd.com.
